Gossamer Bio Inc (GOSS)
0.74
-0.03
(-4.06%)
USD |
NASDAQ |
May 03, 16:00
0.7351
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Market Cap: 167.40M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 167.40M |
| May 02, 2024 | 174.48M |
| May 01, 2024 | 160.05M |
| April 30, 2024 | 160.62M |
| April 29, 2024 | 157.52M |
| April 26, 2024 | 151.11M |
| April 25, 2024 | 151.57M |
| April 24, 2024 | 160.23M |
| April 23, 2024 | 166.86M |
| April 22, 2024 | 168.08M |
| April 19, 2024 | 177.31M |
| April 18, 2024 | 182.33M |
| April 17, 2024 | 185.50M |
| April 16, 2024 | 185.68M |
| April 15, 2024 | 193.57M |
| April 12, 2024 | 201.94M |
| April 11, 2024 | 218.25M |
| April 10, 2024 | 225.51M |
| April 09, 2024 | 225.58M |
| April 08, 2024 | 243.63M |
| April 05, 2024 | 232.35M |
| April 04, 2024 | 241.37M |
| April 03, 2024 | 250.40M |
| April 02, 2024 | 259.42M |
| April 01, 2024 | 286.49M |
| Date | Value |
|---|---|
| March 28, 2024 | 266.19M |
| March 27, 2024 | 263.93M |
| March 26, 2024 | 277.47M |
| March 25, 2024 | 295.51M |
| March 22, 2024 | 304.54M |
| March 21, 2024 | 297.77M |
| March 20, 2024 | 304.54M |
| March 19, 2024 | 313.56M |
| March 18, 2024 | 311.30M |
| March 15, 2024 | 329.35M |
| March 14, 2024 | 315.82M |
| March 13, 2024 | 322.58M |
| March 12, 2024 | 315.82M |
| March 11, 2024 | 302.28M |
| March 08, 2024 | 311.30M |
| March 07, 2024 | 313.56M |
| March 06, 2024 | 340.63M |
| March 05, 2024 | 327.09M |
| March 04, 2024 | 327.09M |
| March 01, 2024 | 311.30M |
| February 29, 2024 | 318.07M |
| February 28, 2024 | 306.79M |
| February 27, 2024 | 277.47M |
| February 26, 2024 | 286.27M |
| February 23, 2024 | 293.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
91.29M
Minimum
Mar 17 2023
1.634B
Maximum
Dec 11 2019
697.00M
Average
714.37M
Median
Dec 31 2020
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.072B |
| TG Therapeutics Inc | 2.502B |
| Replimune Group Inc | 426.65M |
| 89bio Inc | 877.97M |
| Moderna Inc | 47.90B |
Market Cap Related Metrics
| Price to Book Value | 2.667 |
| Price | 0.74 |
| Earnings Yield | -179.7% |